top of page

The Washington State Senate has approved a bill to create a task force promoting research into psilocybin and developing a pathway for legal access to the psychedelic.

The legislation from Sen. Jesse Salomon (D)—which was effectively gutted in an earlier Senate committee to exclude original regulated access provisions—cleared the full chamber in a 41-7 vote on Tuesday. It now heads to the House.

Senate Democrats cheered the passage, but advocates remain disappointed about the extent to which the bill was watered down in committee.

Salomon filed a floor amendment to reinsert language providing for access to psilocybin services through a pilot program, but he ultimately withdrew it without forcing a vote.

There is so mushroom in our hearts for this bill that just passed the Senate! 🍄 ❤️ #SB5263, sponsored by Sen. Jesse Salomon, will create a task force to look into creating a safe and regulated process for access to psilocybin for wellness purposes in our state. #WALegpic.twitter.com/aiOtjAJWPx

— WA Senate Democrats (@WASenDemocrats) March 7, 2023


“This bill before us is directing agencies to study how to apply this interesting intriguing idea into a legal framework,” the sponsor said on the floor on Tuesday. “So we will not be adopting a policy to actually start giving the substance to people, but we need to get the agencies ready to move forward and allow them to cast a wide net to figure out what exactly the best way forward is. This is a huge step in the right direction.”

The measure as introduced would have allowed adults 21 and older to lawfully use psilocybin in a supervised setting with a trained facilitator. It also would have required regulators to accept license applications for product manufacturers, service centers and product testing labs by September 2025.

That 81-page bill was reduced to an eight-page bill mandating the formation of a task force to explore regulatory pathways for the psychedelic in the future. It’s possible, of course, that House lawmakers may seek to further amend it in their chamber.

The task force would be responsible for developing “a long-term strategic plan for ensuring that psilocybin services become and remain a safe, accessible, and affordable option for all persons 21 years of age and older in this state for whom psilocybin may be appropriate or as part of their indigenous religious or cultural practices,” the text says.

“When I first introduced this policy idea last session, I thought it was a good idea and I was excited about it,” Salomon said on Tuesday. “But I had no idea how much interest and need and demand would be expressed about this policy. This policy is about giving access regulated access to psilocybin.”

Sen. Karen Keiser (D), who contributed the most significant amendments scaling back the original bill in committee, said she looked forward to the revised version being enacted, “setting up the infrastructure so we’re ready to go in the next year or two.”

A GOP senator also spoke about how he and another colleague went into the debate on psilocybin therapy legislation with “our arms completely folded,” believing the proposal to be the “craziest thing we’d ever heard and couldn’t even imagine being able to ever vote for this.”

It was the testimony of experts, medical professionals and people with direct experience benefitting from psilocybin that he credited for getting him to a “yes” on this amended version. The senator expressed appreciation to the sponsor for “continuing to push the idea—to grant that air of legitimacy and to continue to put scholars and people who have been the beneficiaries of psilocybin usage in front of all of us.”

Washington is one of more than a dozen states where lawmakers are pursuing psychedelics reform this session as interest in the science and medical potential of these substances expands.

Hawaii’s Senate and House passed three psychedelics research bills on Tuesday, for example.

Also this week, Missouri lawmakers approved a GOP-led bill in committee to promote research into the therapeutic potential of certain psychedelics such as psilocybin, MDMA and ketamine.

Last week, a New Mexico House committee passed a measure that would create a state body to study the possibility of launching a psilocybin therapy program for patients with certain mental health conditions who could benefit from using the psychedelic.

Those are just a few examples of the types of reforms that legislators across the country are considering this session.

An analysis published in an American Medical Association journal last year concluded that a majority of states will legalize psychedelics by 2037, based on statistical modeling of policy trends.

Back in Washington, lawmakers are also advancing legislation this session on interstate cannabis commerce and employment protections for marijuana consumers. A bill to legalize home cultivation of cannabis stalled, however.

Delaware Marijuana Sales Bill Heads To Floor After House Approves Complementary Legalization Measure

 
 
 

A Washington State Senate committee approved a massive overhaul to a psilocybin services bill on Thursday, gutting sections that would have legalized use of the psychedelic drug by adults—and reform advocates in the state are blaming the governor for being behind the move.

As originally filed last month, SB 5263 would have put Washington on the road to regulating psilocybin services much like its neighbor Oregon. Adults 21 and older would have been able to legally use the drug with the support of a trained facilitator, and regulators would have begun accepting license applications for product manufacturers, service centers and product testing labs by September 2025.

The new changes to the bill made in the Senate Labor and Commerce Committee scrap those provisions, constraining the proposal to simply studying the issue. Rather than commit to legalization, the revised bill would aim to “provide advice and recommendations on developing a comprehensive regulatory framework for access to regulated psilocybin.”

While the revised legislation still makes references to potential licensing of businesses and service providers in the future, it specifies no timeline for those provisions to take effect.

Mason Marks, a senior fellow and project lead on the Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School, said the bill “basically kicks the can down the road.”

“The replacement bill removes the core sections of SB 5263, transforming it from a supported adult-use bill to a policy analysis bill,” Marks told Marijuana Moment. “The substituted bill approved by Labor and Commerce would merely create a task force and a state psilocybin board to research the creation of a regulated psilocybin program.”

He described a commitment to further study as “the most conservative approach a state can take” to reform.

Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Observers—and even some lawmakers—were caught off guard by the sweeping changes in the amendment adopted Thursday. SB 5263’s sponsor, Sen. Jesse Salomon (D), told Marijuana Moment: “I don’t have a comment yet.”

“I am going over the implications of the amendment and frankly, sorting out how I feel about it,” he said in an email following the vote. “Obviously we wanted the policy as a whole to pass this year, but this amendment and the apparently wide support (we will know for sure as soon as the vote is recorded) is encouraging.”

The Senate panel passed the revised legislation on a bipartisan voice vote, with all or nearly all members of the panel voting in favor.

“I think the key is demonstrating this is not a scary future if we move the broader policy,” Salomon continued. “Clearly the only way for us to do that now is in steps.”

Lawmakers adopted the substitute with little discussion or debate at Thursday’s hearing. Ranking Republican member Sen. Curtis King said he supported the revised bill and thanked Sen. Karen Keiser (D) for sponsoring the amendment.

“I want to compliment you on your work with this proposed sub,” King told Keiser, who is also the committee chair. “I think you’ve taken a very thorny issue and put some sideboards around it.”

Keiser in turn thanked King and acknowledged the measure will need further changes. The 55-page substitute, she admitted, “is not a refined bill.”

“We did it in the last two days, pretty much,” she said. “It will be going to Ways and Means, and we can further improve it there.”

The Senate Ways and Means Committee is expected to hear the bill on Tuesday.

Reached via email Thursday evening, Keiser told Marijuana Moment that she offered the amendment because of “grave concerns about the original bill, as I was witness to the problems that grew out of passing medical cannabis without enough structure for a regulatory system that ensured a safe product and a licensing system that had real oversight.”

“I have worked to keep the bill moving and advancing the process to open psilocybin access with a regulated, and transparent product that has great potential and perhaps some risks that [must] be managed too,” Keiser said. “In addition, the task force set up last year will not be submitting its recommendations until December of this year, so passing a comprehensive bill before the task force is able to do its job, is the definition of putting the cart before the horse.”

Keiser denied speculation from some reform advocates who suspected that Gov. Jay Inslee (D) had requested the original bill be scuttled.

“I did not have any discussion or contact with the governor about this bill, although I did hear that the governor was not in support of the original proposal,” the senator said. “For that matter, I have no idea if the governor has any position on the substitute bill we passed.”

But Jaime Smith, executive director of communications for Inslee, told Marijuana Moment that the governor’s office had “been in touch with Sen. Saloman about his legislation” and “discussed the bill with Sen. Keiser as well,” although she offered no specifics.

“The substitute includes some provisions we appreciate, such as altering the membership of the workgroup to include some perspectives we think will be valuable and additional time for the workgroup to complete its report,” Smith said. “We’ll continue watching the bill as it moves forward and remain very interested in the work group’s efforts.”

This is the second time Salomon has sought to legalize psilocybin services through the legislature. Early last year, he introduced a similar measure, SB 5660. While that measure received a hearing, it did not ultimately advance out of committee.

“Last year the bill died,” Salomon told Marijuana Moment. “That is not the case this year. I guess that could be called progress.”

Advocates at the Psychedelic Medicine Alliance Washington, who supported legalization, expressed some disappointment with the substitute bill but said they will push “for this new bill to be as flexible and inclusive as possible.”

#SB5263 the original bill introduced this year unfortunately will not be moving forward. Instead, this new substitute bill, introduced late Wednesday afternoon, was passed this morning. This bill will largely inform what may happen next in WA state re psilocybin policy.

— Psychedelic Medicine Alliance WA (@pma_wa) February 16, 2023


“Gov. Inslee forced the Senate to amend SB5263 to remove Psilocybin Services and has turned it into an unnecessary research bill, putting Washington on par with states like Arizona and Oklahoma,” the group said in an email blast to supporters, “leaving us in the dust behind Oregon and Colorado who have both passed initiatives to increase access to psychedelics.”

“Despite strong bipartisan support and broad public support for increased access to alternative medicines, the governor single handedly decided to gut our bill,” it said.

Separately on Thursday, a Washington House panel advanced a bill to legalize home cultivation of cannabis. Washington is the only state where cannabis is legal that classifies homegrow as a felony.

That House panel advanced two other cannabis-related bills: One, HB 1650, would allow local governments to enact bans on marijuana businesses only with voters’ approval. The other, HB 1822, would allow operators of short-term rentals, such as AirBnbs, to provide adult guests with small amounts of complimentary alcohol or cannabis.

Earlier in the week, the same committee approved an amended measure that would allow Washington marijuana businesses to engage in interstate commerce once changes in federal cannabis policy allow it. A companion bill on the Senate side cleared its own committee hurdle last month.

Bills to promote social equity in the cannabis industry and provide employment protections for adults who use marijuana have also advanced through initial Senate committee votes this session.

Separately, state lawmakers are reconsidering drug possession penalties and related issues. Following a state Supreme Court decision in February 2021 that invalidated the state’s felony law against drug possession, lawmakers enacted a temporary criminalization policy that is set to expire on July 1.

Teen Marijuana Use Trends Downward As More States Legalize It For Adults, Federal Survey Finds

Photo courtesy of Wikimedia/Workman

 
 
 

Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page